Position in RDY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$39,556,900
+$39,354,308 QoQ
Shares Held
2,856,094
+20581.3% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 90.70982957843825.ToString("F0")%
Shared 9.290170421561756.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $555,929,631 across 34 Drug Manufacturers - Specialty & Generic names. RDY ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
277,983 | $164,838,356 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
611,264 | $80,527,917 | |
| 3 | VTRS |
Viatris Inc
|
5,569,529 | $75,244,331 | |
| 4 | ZTS |
Zoetis Inc.
|
569,669 | $67,340,568 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
This page
|
2,856,094 | $39,556,900 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,261,569 | $31,435,808 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
732,290 | $22,056,572 | |
| 8 | HLN |
Haleon plc
|
1,525,032 | $15,265,566 |
All Filings in RDY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,556,900 | 2,856,094 | Shares | Defined | 2026-05-13 | |
| 2024-03-31 | $202,592 | 13,810 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||